Andy Dearth

UMDF Helps Launch Mitochondrial Disease Advocacy Coalition, Uniting 17 Groups Behind a Single Voice on Capitol Hill

Sep 4, 2026

New coalition brings together organizations from across the mitochondrial disease community to accelerate research funding, advance...

Aug 12, 2026

Signup to receive the UMDF newsletter in your email monthly at umdf.org/newsletter-signup. A Recap of Mito Med 2026 Mito Med 2026 brought...

Jun 16, 2026

U.S.-based United Mitochondrial Disease Foundation (UMDF) and Australia-based Mito Foundation are proud to announce eight research grants...

Mar 5, 2026

UMDF is disappointed by the U.S. Food and Drug Administration’s (FDA) decision not to approve idebenone for Leber Hereditary Optic Neuropathy...

Feb 10, 2026

Signup to receive the UMDF newsletter in your email monthly at umdf.org/newsletter-signup. February is National Heart Month and Rare Disease...

Jan 26, 2026

Signup to receive the UMDF newsletter in your email monthly at umdf.org/newsletter-signup. UMDF Marks 30 Years of Serving the Mitochondrial...

Dec 5, 2025

Signup to receive the UMDF newsletter in your email monthly at umdf.org/newsletter-signup. NY Jets Player and Coach Team Up to Support Mito...

Dec 3, 2025

UMDF has teamed up with the Muscular Dystrophy Association (MDA) to co-fund two new research projects to accelerate the development of...

Nov 7, 2025

Signup to receive the UMDF newsletter in your email monthly at umdf.org/newsletter-signup. FDA Approves First-Ever TK2d Therapy Earlier this...

Nov 3, 2025

11/3/25, 5pm EST — Earlier today, the U.S. Food and Drug Administration (FDA) approved UCB’s Kygevvi (doxecitine and doxribtimine) to...